Embolization particles are irregularly-shaped, biocompatible, hydrophilic, non-resorbable particles. These embolization particles are intended to provide vascular occlusion or reduction of blood flow within target vessels upon selective placement through a variety of catheters. Embolization particles are used for the embolization of arteriovenous malformations and hyper vascularized tumors, including symptomatic uterine fibroids. It is a minimally invasive therapy used in many procedures as a part of interventional radiology. Embolization is used to stop bleeding as well as to treat tumors that cannot be removed by surgery by stopping its blood supply. This report studies the global market for embolization particle in terms of revenue (USD million) from 2019 to 2024.

EMBOLIZATION PARTICLE MARKET OUTLOOK

The global embolization particle market has gained profitable growth owing increasing demand of embolization particles for interventional radiology and interventional cardiovascular procedure. The market is further boosted by technological advancements in embolization particles and increasing preference for minimally invasive procedures. Moreover, the market is expected to show robust growth during the forecast period due to surging government spending on pharmaceutical RD in emerging nations. recent advances in microsphere technologies and favourable reimbursement scenario are further expected to propel this market growth. However, the global embolization particle market is hindered by scarcity of interventional neuroradiologists and interventional neuroradiology (INR) labs, strict regulations and risks such as coagulation of vital veins blood supply.

Get Free Sample Report for More Industry Insights: https://www.axiommrc.com/request-for-sample/hc1822embolization-particle-market

EMBOLIZATION PARTICLE MARKET SEGMENTAL OVERVIEW

The report analyses the global embolization particle market based on product type, application, end user and geography. 

EMBOLIZATION PARTICLE MARKET BY PRODUCT TYPE 

The market is segmented into various product type, which includes radioembolization particles, microspheres, drug-eluting beads and others. Among these, the radioembolization particles segment dominated the market in 2017 and is expected to grow at a lucrative growth rate during the forecast period, due to its use in the treatment of cancer. 

EMBOLIZATION PARTICLE MARKET BY APPLICATION 

The embolization particle finds applications into peripheral vascular disease, neurology, oncology, urology and others. In 2017, the oncology application dominated the global market, owing to increasing use of embolization particle in cancer treatments. Radioembolization is a cancer treatment in which radioactive particles are delivered to a tumor through the bloodstream. The particles lodge in the tumor and emit radiation that kills cancer cells. 

EMBOLIZATION PARTICLE MARKET BY END USER 

The market is segmented into various end users, which includes hospitals, ambulatory surgical centres and clinics. Among these, the hospitals segment dominated the market in 2017 and is expected to grow at a lucrative growth rate during the forecast period, due to surging number of hospitals using embolization particle for various treatments. 

EMBOLIZATION PARTICLE MARKET BY GEOGRAPHY 

By geography, the global embolization particle market is segmented into North America, Europe, Asia Pacific and Rest of the World. North America dominated the global embolization particle market in 2017, due to advanced hospitals infrastructures, and availability of skilled healthcare professionals. Presence of strong economic condition and huge development in the healthcare domain are further fuelling the market growth. Moreover, Asia Pacific is the anticipated to grow at a fastest growth rate during the forecast period 2019 to 2024 among other regions. The higher rate of the growth is fuelled by increasing emphasis on rapid diagnosis and treatment of cancer, changing lifestyle and increasing prevalence of cancer among geriatric population.

EMBOLIZATION PARTICLE MARKET KEY PLAYERS

The demand for embolization particle market is gauzed by market attractiveness tool and company market share. The key players of global embolization particle market include Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific Corporation, Terumo Corporation, HENGRUI Medical, Interface Biomaterials B.V. and Alicon among others. Strategies such as product innovation and collaborations are adopted by global players as well as regional players, to maintain the product superiority, thus interpreting market sustainability.

Request For Best Pricing :-https://www.axiommrc.com/buy_now/hc1822embolization-particle-market

About Us:

Axiom Market Research Consulting™ is a full-service market research and data analytics company providing key market intelligence to global companies to take informed business decisions pertaining to their marketing strategy, investments, new product launches, market competition, consumer or end users, social media trends etc. 

Axiom Market Research Consulting™ offers market research services such as syndicated market research, custom market research, business consulting, and consumer/end user surveys. Under Business to Consumer (B2C) market research offerings, Axiom MRC assists its clients in finding quantitative information/preferences of its brands and services such as, awareness, usages, satisfaction, tracking, ethnicity etc. Axiom MRC offers data collection services through online surveys, social media, data processing and interpretation.

Axiom MRC with its experienced team of research and data analysts, has delivered more than 5000+ Market Research Projects, 3800+ Data Analytics Projects, 1200+ Business Support Projects and has a 800+ Global Client Base. Axiom Market Research Consulting™ aims to become the preferred market research and data Analytics Company by providing key market intelligence solutions for client’s business growth.

Contact Us:

Axiom Market Research Consulting™

3 Germay Dr. Ste 4 - 4666

Wilmington DE 19804

U.S.:- + 1 (845) 875-9786

U.K.:- + 44 (0) 20 3286 9707

Email: sales@axiommrc.com

Website: https://www.axiommrc.com/

Follow On

LinkedIn:https://www.linkedin.com/company/axiom-market-research-and-consulting/

Twitter:  https://twitter.com/AxiommrcCom